In a report released today, Korinne Wolfmeyer from Piper Sandler maintained a Hold rating on Hims & Hers Health (HIMS – Research ...

Piper Sandler analyst Korinne Wolfmeyer maintained a Buy rating on e.l.f. Beauty (ELF – Research Report) today and set a price target of $165.00. The company’s shares closed yesterday at $104.16.

Piper Sandler’s Korinne Wolfmeyer also views the cheaper share price as a “disconnect with the relative strength and resilience ELF delivers.” “There may be a (very) slight headwind to ...

Joshua Raskin: Perfect. Thanks a lot. Operator: Thank you. [Operator Instructions] Next question comes from the line of ...

NEW YORK, Oct. 31, 2024 /PRNewswire/ -- Piper Sandler Companies (NYSE: PIPR), a leading investment bank, and BC Partners Credit, the $8 billion credit arm of international investment firm BC ...

NEW YORK - Piper Sandler Companies (NYSE: PIPR), a prominent investment bank, and BC Partners Credit have announced a strategic alliance aimed at enhancing debt capital market access for financial ...

On Monday, Piper Sandler showed a positive outlook for shares of USCB Financial Holdings (NASDAQ: USCB), shifting its rating from Neutral to Overweight and boosting the price target to $20.00 from ...

Piper Sandler raised the firm’s price target on Mondelez (MDLZ) to $84 from $74 and keeps an Overweight rating on the shares. The firm notes Mondelez reported better than expected Q3 EPS and ...

Boston Beer (NYSE:SAM – Free Report) had its price objective boosted by Piper Sandler from $325.00 to $330.00 in a research note issued to investors on Friday morning, Benzinga reports.

Piper Sandler initiated coverage of Camp4 Therapeutics (CAMP) with an Overweight rating and $18 price target The company is is pioneering development of regulatory RNAs as a novel therapeutic ...